Back to results
RecruitingPhase 3

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

NCT07076407

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Harmonex Neuroscience Research

Dothan, Alabama, United States

+41 additional locations

Contact

Xenon Medical Affairs

1-604-484-3300XenonCares@xenon-pharma.com
View on ClinicalTrials.gov
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3) — TrialFind